Long intergenic non-protein coding RNA 2609 (LINC02609)

Long intergenic non-protein coding RNA 2609 (LINC02609) is a long non-coding RNA that does not encode a protein but is involved in the regulation of gene expression and cellular processes. It is significantly upregulated in renal cell carcinoma, especially clear cell subtype, and is associated with poor prognosis. Mechanistically, LINC02609 acts as a competing endogenous RNA modulating APOL1 expression by sponging miR-149-5p, impacting lipid metabolism, endoplasmic reticulum homeostasis, and cellular proliferation. Its expression is also directly regulated by HIF-2α, linking hypoxia signaling to metabolic and tumorigenic pathways. LINC02609 serves as both a diagnostic and prognostic biomarker and is under investigation as a potential therapeutic target in kidney cancer, primarily due to its influence on tumor cell survival, migration, and immune interaction signatures[2][4][6].

Other names

LINC02609long intergenic non-protein coding RNA 2609

LINC02609's mechanism of action involves its potential as a biomarker for immunotherapy response in renal cell carcinoma. It modulates tumor progression by regulating the MAPK pathway and affects lipid storage and ER homeostasis via APOL1 regulation.